• Flanders Investment & Trade
  • Team Vesalius

Dr. Els Beirnaert is the current CEO of Aelin Therapeutics in Leuven (Flanders), a biotech startup focused on the discovery and development of breakthrough Pept-in™-based therapeutics.

Els Beirnaert

Aelin Therapeutics


She offers two decades of experience in drug development, venture and business development. In 2001, she is one of the founders of biopharma company Ablynx – now a Sanofi subsidiary.

She helped start up many life sciences companies, serving as the Head of New Ventures at the Flanders Institute of Biotechnology (VIB) and a board member for biotech firms Confo Therapeutics, Q-Biologicals and Multiplicom.

Team Vesalius visionairies

Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare

Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?